Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib.
Cohen E, Bozonnat A, Battistella M, Calvani J, Vignon-Pennamen MD, Rivet J, Moins-Teisserenc H, Ta VA, Ram-Wolff C, Bouaziz JD, Mahevas T, Bagot M, Mourah S, Louveau B, Sicre de Fontbrune F, Peffault de Latour R, de Masson A, Battesti G.
Cohen E, et al.
J Eur Acad Dermatol Venereol. 2024 Jan;38(1):e32-e34. doi: 10.1111/jdv.19408. Epub 2023 Aug 23.
J Eur Acad Dermatol Venereol. 2024.
PMID: 37561935
No abstract available.